Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.32 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 6/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 6/20 | 0.30 |
| ▸ | PPARD | Q03181 | 6/20 | 0.30 |
| ▸ | PPARA | Q07869 | 6/20 | 0.30 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.30 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL292695 | 1.00 | THRB (0.38) | THRBHSD17B10GMNNTP53POLB | |
| SCHEMBL292697 | 0.79 | THRB (0.39) | THRBHSD17B10GMNNTP53POLB | |
| SCHEMBL11144040 | 0.74 | CES2 (0.43) | THRBHSD17B10GMNNTP53POLB | |
| SCHEMBL6405359 | 0.72 | THRB (0.42) | THRBHSD17B10GMNNTP53POLB | |
| SCHEMBL8999212 | 0.71 | THRB (0.46) | THRBHSD17B10GMNNTP53POLB | |
| SCHEMBL2537690 | 0.70 | — | — | |
| SCHEMBL11104975 | 0.70 | MEN1 (0.36) | THRBHSD17B10GMNNTP53POLB | |
| SCHEMBL8542086 | 0.69 | TSHR (0.41) | THRBHSD17B10GMNNTP53POLB | |
| SCHEMBL9453227 | 0.69 | TSHR (0.46) | THRBHSD17B10GMNNTP53POLB | |
| SCHEMBL10408933 | 0.69 | TSHR (0.46) | THRBHSD17B10GMNNTP53POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729203-B2 | Polymer composition | CONTAMAC LIMITED (GB) | 2014-05-20 | — | — | US | disclosed |
| EP-2427509-A1 | POLYMER COMPOSITION | Contamac Limited (GB) | 2012-03-14 | — | — | EP | disclosed |
| US-20120053313-A1 | POLYMER COMPOSITION | CONTAMAC LIMITED (GB) | 2012-03-01 | — | — | US | disclosed |
| WO-2010128266-A1 | POLYMER COMPOSITION | CONTAMAC LIMITED (GB) | 2010-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053313-A1 | POLYMER COMPOSITION | UACA, CRYAA, CRYZ | THRB 4392/4885HSD17B10 2645/4885GMNN 1037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.